Xariban 20 Tablet

Xariban 20 offers a predictable anticoagulant effect with rapid onset of action and does not require routine coagulation monitoring, enhancing patient compliance. The tablet is administered orally, typically once daily, with or without food, depending on the indication. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated in individuals with active pathological bleeding or significant hypersensitivity to the drug.

Potential adverse effects include bleeding complications, which necessitate careful assessment of bleeding risk prior to initiation. Xariban 20 should be used under strict medical supervision, with appropriate dose adjustments or discontinuation in cases of surgery, trauma, or concomitant use of other anticoagulants or antiplatelet agents. This medication plays a critical role in the management of thromboembolic diseases, improving patient outcomes through effective anticoagulation.